Replimune Group Inc (REPL)

12.48 -0.07 (-0.56%) USD  |  NASDAQ  |  Dec 16, 16:00
12.50 +0.02 (+0.12%) After-Hours: 20:00
More

Replimune Group Max Drawdown (5Y): 90.48% for Nov. 30, 2024

Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for REPL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cumulative Total Returns Versus Peers
Start Trial

Historical Data

View Historical Data
Start Trial

Max Drawdown Definition

View Max Drawdown Definition
Start Trial

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Pfizer Inc 54.78%
Bristol-Myers Squibb Co 47.67%
Nuvalent Inc --
NovaBay Pharmaceuticals Inc 99.98%
Palatin Technologies Inc 97.38%

Max Drawdown (5Y) Related Metrics

Alpha (5Y) -18.93
Beta (5Y) 1.256
Annualized Standard Deviation of Monthly Returns (5Y Lookback) 78.35%
Historical Sharpe Ratio (5Y) -0.0275
Historical Sortino (5Y) -0.0675
Monthly Value at Risk (VaR) 5% (5Y Lookback) 26.43%